$PMCB These new applications, if granted, will pr

$PMCB These new applications, if granted, will provide protection for PharmaCyte’s technology for 20 years – until March 2038. “By filing these patent applications, we are continuing the process of pursuing patent protection for 20 years to protect our therapy for all forms of solid malignant tumors. This is particularly important to the company as we are taking steps to embark upon a clinical trial in LAPC,” said PharmaCyte’s Chief Executive Officer, Kenneth L. Waggoner.

https://finance.yahoo.com/news/pharmacyte-bio...00028.html

Consider all my posts my opinion and not advice to buy or sell anything. I post on stocks I own or am considering owning. Do your own DD!